4-Amino-1-[5-O-[(2R, 4S)-2-oxido-4-(4-pyridinyl)-1, 3, 2-dioxaphosphorinan-2-yl]-b-D-arabinofuranosyl]-2(1H)-pyrimidinone | |
---|---|
Trade Name | |
Orphan Indication | Hepatocellular Carcinoma |
USA Market Approval | USA |
USA Designation Date | 2007-08-22 00:00:00 |
Sponsor | Ligand Pharmaceuticals, Inc.;11085 N. Torrey Pines Road, Suite 300;LaJolla, California, 92037 |